SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367920-20-000062
Filing Date
2020-12-11
Accepted
2020-12-11 16:05:19
Documents
15
Period of Report
2020-12-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cnce-20201210.htm   iXBRL 8-K 37149
2 EX-3.1 restatedby-laws.htm EX-3.1 4168
  Complete submission text file 0001367920-20-000062.txt   193017

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20201210.xsd EX-101.SCH 2438
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20201210_cal.xml EX-101.CAL 720
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20201210_def.xml EX-101.DEF 1653
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20201210_lab.xml EX-101.LAB 25942
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20201210_pre.xml EX-101.PRE 13741
8 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20201210_htm.xml XML 12010
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 201383617
SIC: 2834 Pharmaceutical Preparations